Keep Politics Out of Drug Approval
Congress has voted to change the way new prescription drugs are approved, in a way that could endanger patients. The deal now under consideration contains a sweetener for lawmakers who might be wary of such a change (Democrats, that is): substantially increased funding for medical research. It’s very effective politics, but not necessarily good policy.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.